(Q43558989)

24 November 2017

title

Potent, hydroxyl radical-scavenging effect of apomorphine with iron and dopamine perfusion in rat striatum (English)

1 reference

24 November 2017

0 references

1 reference

1 reference

Chen YK

1

1 reference

24 November 2017

Lin HC

series ordinal

2

1 reference

24 November 2017

Liu JC

series ordinal

3

1 reference

24 November 2017

Wan FJ

series ordinal

4

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

24 November 2017

1 reference

24 November 2017

volume

896

1 reference

24 November 2017

issue

1-2

1 reference

24 November 2017

page(s)

165-168

1 reference

In vitro studies of ferritin iron release and neurotoxicity.

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902081-9

Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902081-9

The antioxidants of human extracellular fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902081-9

17Beta-estradiol attenuates oxidative impairment of synaptic Na+/K+-ATPase activity, glucose transport, and glutamate transport induced by amyloid beta-peptide and iron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902081-9

Monoamine metabolism provides an antioxidant defense in the brain against oxidant- and free radical-induced damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902081-9

Increasing striatal iron content associated with normal aging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902081-9

Peripheral and central pharmacokinetics of apomorphine and its effect on dopamine metabolism in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902081-9

CNS dopamine autoreceptors: distribution, pharmacology, and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902081-9

Free radical scavenging properties of apomorphine enantiomers and dopamine: possible implication in their mechanism of action in parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902081-9

Contemporary approaches to the pharmacotherapeutic management of Parkinson's disease: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902081-9

Antioxidant properties of bromocriptine, a dopamine agonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902081-9

Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902081-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(01)02081-9

1 reference

24 November 2017

1 reference